Reporting of cancer clinical trial adverse drug events: A RADAR report

被引：0
|
作者：
Belknap, S. M.
Georgopoulos, C. H.
Weitzman, S. A.
Qualkenbush, L.
Samaras, A. T.
McKoy, J. M.
Edwards, B. J.
Rosen, S. T.
West, D. P.
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Ctr Canc, Chicago, IL 60611 USA
[4] Northwestern Univ, Off Res Integr, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Med, Div Geriatr, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6090
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Reporting of Psychiatric Adverse Events in Randomised Clinical Trials
    Willemen, M. J. C.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    [J]. DRUG SAFETY, 2010, 33 (10) : 936 - 936
  • [22] Adverse events in diabetes drug trial reply
    Buse, John B.
    Falahati, Ali
    [J]. LANCET, 2009, 374 (9696): : 1144 - 1145
  • [23] Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols
    Akoh Walter Ebile
    Jerome Ateudjieu
    Martin Ndinakie Yakum
    Marceline Ngounoue Djuidje
    Pierre Watcho
    [J]. BMC Medical Ethics, 16
  • [24] Bisphosphonate use and osteonecrosis of the jaw: Pharmacovigilance and reporting of this serious adverse event from the Research on Adverse Drug Events and Reports (RADAR) project
    Edwards, B. J.
    Gounder, M.
    McKoy, J.
    Raisch, D.
    Farrugia, M.
    Cesar, M.
    Marx, R.
    Ruggiero, S.
    Dimopoulos, M.
    Bennett, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols
    Ebile, Akoh Walter
    Ateudjieu, Jerome
    Yakum, Martin Ndinakie
    Djuidje, Marceline Ngounoue
    Watcho, Pierre
    [J]. BMC MEDICAL ETHICS, 2015, 16
  • [26] Adverse events reporting
    Higuchi, K.
    [J]. CLINICAL DRUG INVESTIGATION, 2007, 27 (03) : 225 - 225
  • [27] Adverse Events Reporting
    K. Higuchi
    [J]. Clinical Drug Investigation, 2007, 27 : 225 - 225
  • [28] Reporting of adverse events
    Woolf, A
    Litovitz, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14): : 1410 - 1411
  • [29] Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs
    Belknap, S. M.
    Georgopoulos, C. H.
    West, D. P.
    Yarnold, P. R.
    Kelly, W. N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 231 - 236
  • [30] Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
    Basch, Ethan
    Dueck, Amylou C.
    Rogak, Lauren J.
    Minasian, Lori M.
    Kelly, William Kevin
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Seisler, Drew
    Atherton, Pamela J.
    Paskett, Electra
    Carey, Lisa
    Dickler, Maura
    Heist, Rebecca S.
    Himelstein, Andrew
    Rugo, Hope S.
    Sikov, William M.
    Socinski, Mark A.
    Venook, Alan P.
    Weckstein, Douglas J.
    Lake, Diana E.
    Biggs, David D.
    Freedman, Rachel A.
    Kuzma, Charles
    Kirshner, Jeffrey J.
    Schrag, Deborah
    [J]. JAMA ONCOLOGY, 2017, 3 (08) : 1043 - 1050
12345